Antiaggregation in Primary Prevention of Vascular Access for Hemodialysis

Summary

This is a prospective study consisting in testing whether systematic use of aspirin is beneficial for primary prevention of vascular access for hemodialysis attested by doppler ultrasound exam. The investigators will study aspirin resistance in the population of patients undergoing hemodialysis. The investigators will test sensibility of resistant patients to aspirin dose escalation. PFA-100 is the biologic test used in this study to define aspirin resistance.

Timeline

Start

2013-11

Primary completion

2014-09

Completion

2015-03

Drugs

Indications